Tag Archives: Sunshine Act

ILN Today Post

“Sunshine Act” Mineiro

Em 29 de Dezembro de 2017 entrou em vigor o Decreto 47.334, que regulamenta o chamado “Sunshine Act” Mineiro (Lei do Estado de Minas Gerais 22.440/2016).

Conforme disposto em tais atos normativos, devem ser declaradas ao Governo do Estado de Minas Gerais, anualmente, até o último dia útil do mês de janeiro, quaisquer relações que configurem potenciais conflitos de interesses, mantidas no ano anterior entre profissionais de saúde e matrizes e subsidiárias de empresas que atuem nos diversos segmentos da indústrias de medicamentos, órteses, próteses, equipamentos e implantes.

Read More

Read full article
ILN Today Post

Client Alert – Recent Rejection of Sunshine Act Data Submissions Pushes Back Deadlines

Implementation of the Sunshine Act continues to encounter stumbling blocks. On August 15, 2014 the Centers for Medicare and Medicaid Services (“CMS”) announced that it would be withholding one-third of the records it received from drug and medical device manufacturers under the Sunshine Act due to data inconsistencies. CMS indicated that the flawed submissions will not be published in the Open Payments System database that is scheduled to go public on September 30, 2014. Rather, CMS will be returning the flawed data to manufacturers and group purchasing organizations (“GPOs”) to be corrected and resubmitted. The resubmitted data will not be published until June 2015.  More…

Read full article

HEALTH REFORM: Federal Transparency Is Now a Reality: Challenges and Opportunities for Pharma, Devices, and PBMS

On March 23, 2010, President Obama signed H.R. 3590, the Patient Protection and Affordable Care Act (“PPACA“), into law. Following the enactment of PPACA, H.R. 4872, the Health Care and Education Reconciliation Act of 2010, was enacted into law on March 30, 2010, “reconciling” and revising portions of PPACA. This expansive legislation includes provisions from the Physician Payment Sunshine Act (“Sunshine Act“) introduced previously by Senators Charles Grassley (R-IA) and Herb Kohl (D-WI) in 2009.[1] Early versions of the Sunshine Act were endorsed by the Pharmaceutical Research and Manufacturers of America, the Advanced Medical Technology Association, the American Medical Association and individual industry organizations.[2]

Read full article